cjc-1295 no dac ipamorelin mechanism gh release / Blend CJC-1295 No DAC + Ipamorelin

Ipamorelin is a peptide that stimulates growth hormone release through a different pathway (often categorized as a GH secretagogue)

In experimental endocrinology, this dual-agonist blend is used as a tool compound to investigate GH/IGF-1 axis regulation, pituitary signaling and pulsatile growth hormone secretion patterns in in vitro and in vivo research models

Carpal tunnel syndrome has been reported with GH therapy

Best for convenience and sustained growth hormone support

Best Peptides to Stack with IGF-1 LR3 GH secretagogues like CJC-1295 and Ipamorelin increase plasma GH and IGF-1 levels, mimicking natural hormone pulses while reducing side effects. Merriam et al., Endocrinology and Metabolism Clinics Sample Peptide Stack Protocol with IGF-1 LR3 Goal: Muscle growth, fat loss, and joint recovery IGF-1 LR3 4080 mcg per day (post-workout or split AM/PM) CJC-1295 w/ DAC 2 mg once weekly Ipamorelin 100 mcg 23x daily (AM, pre-bed, post-training) TB-500 25 mg weekly (split dose) BPC-157 250500 mcg 12x daily for site-specific healing Note: Peptide timing should support circadian rhythm, with GH secretagogues ideally used pre-bed or post-training for maximum recovery

Injection site does not meaningfully affect timing-dependent GH response